Immediate Impact
3 by Nobel laureates 4 from Science/Nature 59 standout
Citing Papers
The role of ROS in tumour development and progression
2022 Standout
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
2021 Standout
Works of Christopher A. Maack being referenced
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies.
2003
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Christopher A. Maack | 81 | 192 | 157 | 7 | 275 | |
| Michael O. Idowu | 74 | 98 | 144 | 8 | 274 | |
| Regina Marcinek | 27 | 155 | 145 | 7 | 331 | |
| C. Dony | 45 | 173 | 231 | 6 | 336 | |
| Giulietta A. Perrone | 90 | 101 | 166 | 10 | 331 | |
| S. von Laue | 53 | 231 | 118 | 7 | 320 | |
| Sinan Tanyolaç | 47 | 94 | 92 | 10 | 246 | |
| Kimberly Yeatts | 73 | 47 | 118 | 5 | 248 | |
| Cédric Cortijo | 40 | 78 | 188 | 7 | 313 | |
| Rosanne St. Bernard | 63 | 48 | 209 | 9 | 316 | |
| John A. Phillips | 25 | 146 | 144 | 9 | 319 |
All Works
Loading papers...